Dapaglifozin also inhibited kidney ferroptosis in a murine model of DKD, and the β-hydroxybutyrate-calcium/calmodulin-dependent protein kinase kinase 2 (BHB-CaMKK2) axis seems to play a key role in this protective effect [65]. Here, CAMKK2 is linked to diabetic kidney disease.